RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):876-82. doi: 10.1161/ATVBAHA.110.221945. Epub 2011 Jan 27.

Abstract

Objective: Notch signaling has a critical role in vascular development and morphogenesis. Activation of Notch in endothelial cells led to a senescence-like phenotype with loss of barrier function. Our objective was to understand the molecular pathways mediating this phenotype.

Methods and results: Human primary endothelial cells increase expression of Notch receptors and ligands during propagation in vitro toward natural senescence. This senescence was induced at low passage with Notch activation. We characterized the pathways activated downstream of Notch signaling. Notch was activated by Delta-like 4 ligand or constitutively active Notch receptors and measured for cell proliferation, migration, and sprouting. Notch signaling triggered early senescence in low-passage cells, characterized by increased p53 and p21 expression. The senescence phenotype was associated with hyperpermeability of the monolayer, with disrupted vascular endothelial cadherin and β-catenin levels and localization. Consistent with changes in cell shape and contact, we demonstrated that Notch activation increases myosin light chain phosphorylation by activating Rho kinase. Inhibition of Rho abrogated Notch-induced myosin light chain phosphorylation and led to enhanced barrier function by reorganizing F-actin to β-catenin-containing cell-cell adherens junctions.

Conclusions: Our findings show that RhoA/Rho kinase regulation by Notch signaling in endothelial cells triggers a senescence phenotype associated with endothelial barrier dysfunction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Adaptor Proteins, Signal Transducing
  • Adherens Junctions / metabolism
  • Animals
  • Antigens, CD / metabolism
  • Cadherins / metabolism
  • Calcium-Binding Proteins
  • Cell Movement
  • Cell Proliferation* / drug effects
  • Cells, Cultured
  • Cellular Senescence* / drug effects
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Mice
  • Mitogen-Activated Protein Kinases / metabolism
  • Myosin Light Chains / metabolism
  • Neovascularization, Physiologic
  • Permeability
  • Phenotype
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Receptor, Notch1 / metabolism
  • Receptors, Notch / genetics
  • Receptors, Notch / metabolism*
  • Signal Transduction* / drug effects
  • Transfection
  • Tumor Suppressor Protein p53 / metabolism
  • beta Catenin / metabolism
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / metabolism
  • rhoA GTP-Binding Protein / metabolism*

Substances

  • Actins
  • Adaptor Proteins, Signal Transducing
  • Antigens, CD
  • CDKN1A protein, human
  • CTNNB1 protein, human
  • Cadherins
  • Calcium-Binding Proteins
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cyclin-Dependent Kinase Inhibitor p21
  • DLL4 protein, human
  • Intercellular Signaling Peptides and Proteins
  • Myosin Light Chains
  • Notch1 protein, mouse
  • Protein Kinase Inhibitors
  • Receptor, Notch1
  • Receptors, Notch
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • beta Catenin
  • cadherin 5
  • RHOA protein, human
  • rho-Associated Kinases
  • Mitogen-Activated Protein Kinases
  • rhoA GTP-Binding Protein